Usana Health Sciences (USNA) Cash from Investing Activities (2016 - 2026)
Usana Health Sciences (USNA) has disclosed Cash from Investing Activities for 16 consecutive years, with $1.1 million as the latest value for Q1 2026.
- Quarterly Cash from Investing Activities rose 100.54% to $1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$10.1 million through Jan 2026, up 95.25% year-over-year, with the annual reading at -$10.1 million for FY2026, 95.25% up from the prior year.
- Cash from Investing Activities for Q1 2026 was $1.1 million at Usana Health Sciences, up from -$3.2 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $1.1 million in Q1 2026, with the low at -$205.1 million in Q4 2024.
- Average Cash from Investing Activities over 5 years is -$14.7 million, with a median of -$3.3 million recorded in 2022.
- The sharpest move saw Cash from Investing Activities skyrocketed 104.81% in 2023, then plummeted 2701.67% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$3.3 million in 2022, then crashed by 123.1% to -$7.3 million in 2023, then tumbled by 2701.67% to -$205.1 million in 2024, then skyrocketed by 98.44% to -$3.2 million in 2025, then soared by 134.71% to $1.1 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at $1.1 million, -$3.2 million, and -$4.2 million for Q1 2026, Q3 2025, and Q2 2025 respectively.